🎗️

Breast Cancer

Our breast cancer program integrates molecular subtyping, targeted therapy trials, and survivorship research to improve outcomes across all stages of disease.

Learn More
3,000+
Patients treated annually
12
Active clinical trials
18%
Five-year survival improvement
85
Publications (2020–2025)

Research Themes

1

Triple-Negative Breast Cancer Genomics

Whole-exome and RNA sequencing to identify actionable mutations and resistance mechanisms in TNBC prevalent in South Asian populations.

2

Immunotherapy Combinations

Evaluating checkpoint inhibitors combined with PARP inhibitors and novel antibody-drug conjugates for advanced disease.

3

Early Detection & Screening

AI-powered mammography interpretation and community health worker–led screening programs in rural Tamil Nadu.

4

Survivorship & Quality of Life

Prospective studies on long-term cardiotoxicity, lymphedema management, and integrative oncology interventions.

Clinical Trials

NCT06234501

Recruiting

Phase II Sacituzumab Govitecan + Pembrolizumab in Metastatic TNBC

PI: Dr. Rama Jayaraj

NCT06234502

Active

Neoadjuvant Olaparib in BRCA-Mutant Breast Cancer

PI: Dr. Shirley Sunder Singh

NCT06234503

Recruiting

AI-Assisted Mammography Screening in Rural Populations

PI: Dr. Arvind Krishnamurthy

Support Breast Cancer Research

Your contribution funds cutting-edge clinical trials and early detection programs that directly improve survival for thousands of women each year.

Donate Now